207_Combined course Presentations
5-FU = Cape in Pre-op Rectal Cancer: NSABP R-04
Capecitabine (825 mg BID) 50.4 Gy
+ Oxaliplatin
Stratify
(50 mg/m2 qw )
• T2 vs. T3 • M vs. F • SP vs. APR
R
CI 5-FU (225 mg/m2/d) 50.4 Gy
+ Oxaliplatin
n=1608
(50 mg/m2 qw)
NSABP R-04, Allegra et al; ASCO GI 2014
Made with FlippingBook